Mega stock gains 0.47 percent as 2025 profit rises
Published on 09/22/2026 at 17:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSMega Lifesciences stock (ISIN TH0765010002) traded at PHP 2.12 on the Philippine Stock Exchange on September 22, 2026, up 0.47 percent from PHP 2.11. The latest available company figures show fiscal 2025 revenue of PHP 85.87 billion and net income of PHP 21.00 billion, giving the stock a market-data and earnings anchor for investors.
Fiscal 2025 delivered growth
According to Reuters on September 22, 2026, Mega reported fiscal 2025 revenue of PHP 85,869.69 million, compared with PHP 81,687.33 million in 2024. That represents growth of 5.1 percent, calculated from the reported annual figures.
Net income reached PHP 21,002.94 million in fiscal 2025, up from PHP 18,749.29 million in 2024. The increase of PHP 2,253.65 million equals 12.0 percent, so earnings expanded faster than revenue during the same reporting period.
Valuation remains a key variable
The Reuters market page lists a forward price-to-earnings ratio of 3.12 and a price-to-sales ratio of 0.79 for the latest available market snapshot on September 22, 2026. These ratios provide a valuation reference alongside the reported 2025 earnings, although they do not by themselves establish a forecast.
The same September 22, 2026 market snapshot shows a dividend yield of 5.56 percent and a quarterly debt-to-equity ratio of 34.77 percent. For investors, the combination of higher earnings, income distribution and balance-sheet leverage is more informative than the daily price change alone.
Stock trades at PHP 2.12
Mega Lifesciences stock stood at PHP 2.12 on the Philippine Stock Exchange as of September 22, 2026, with a daily change of 0.47 percent. The fiscal 2025 comparison remains the central operating reference: revenue increased 5.1 percent year over year, while net income increased 12.0 percent.
Mega Lifesciences key data
- Company: Mega Lifesciences Public Company Limited
- ISIN: TH0765010002
- Ticker: MEGA
- Trading venue: Philippine Stock Exchange
- Price as of September 22, 2026: PHP 2.12
- Fiscal 2025 revenue: PHP 85,869.69 million
- Fiscal 2025 net income: PHP 21,002.94 million
- Sector / Industry: Health care / Pharmaceuticals
